L. Fan

发表

Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer

Wei Xue, Yanqing Wang, C. Chua, 2020, Communications biology.

Single-cell analysis supports a luminal-neuroendocrine trans-differentiation in human prostate cancer

Yanqing Wang, W. Xue, C. Chua, 2020, bioRxiv.

Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate

W. Xue, B. Dong, Z. Ji, 2020, Nature Communications.

Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer

Wei Xue, Pengcheng Zhang, B. Dong, 2022, Nature Cancer.

Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone

Yanqing Wang, W. Xue, B. Dong, 2017, The Prostate.

Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis

Wei Xue, Wei Chen, B. Dong, 2021, Medical Oncology.

Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World Study.

Wei Xue, Lei Li, Wei Chen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Identification of a basal stem cell subpopulation in the prostate via functional, lineage tracing and single-cell RNA-seq analyses

W. Xue, C. Chua, B. Dong, 2019, bioRxiv.

Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations

Wei Xue, Yanqing Wang, Yiran Huang, 2022, Therapeutic advances in medical oncology.

TRIM59 is Suppressed by Androgen Receptor and Acts to Promote Lineage Plasticity and Neuroendocrine Differentiation in Prostate Cancer

Wei Xue, B. Dong, H. Zhu, 2021 .

Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis.

W. Xue, B. Dong, L. Fan, 2021, Clinical genitourinary cancer.

E-cadherin bridges cell polarity and spindle orientation to ensure prostate epithelial integrity and prevent carcinogenesis in vivo

W. Xue, B. Dong, Z. Ji, 2018, bioRxiv.

Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate

W. Xue, B. Dong, Z. Ji, 2020, Nature Communications.

HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1

Yanqing Wang, W. Xue, B. Dong, 2021, International journal of cancer.

Comparative analysis of genomic alterations across castration-sensitive and castration-resistant prostate cancer via circulating tumor DNA sequencing.

W. Xue, B. Dong, L. Fan, 2020, The Journal of urology.

The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study

Wei Xue, Yanqing Wang, Wei Chen, 2021, Clinical and translational medicine.

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

Wei Xue, Pengcheng Zhang, Pengfei Ma, 2023, Cell reports.

Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.

Yanqing Wang, W. Xue, Yiran Huang, 2018, Human pathology.

Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer

Yanqing Wang, W. Xue, B. Dong, 2017, BJU international.

The Microbiome of Prostate Fluid Is Associated With Prostate Cancer

W. Xue, B. Dong, L. Fan, 2019, Front. Microbiol..

Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients

Yanqing Wang, W. Xue, B. Dong, 2018, The Prostate.

Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer

Yanqing Wang, W. Xue, B. Dong, 2017, Journal of Cancer.

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors

Yanqing Wang, W. Xue, Yiran Huang, 2018, BMC Urology.

Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone

Yanqing Wang, W. Xue, B. Dong, 2017, Journal of Cancer.

TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer

Wei Xue, B. Dong, H. Zhu, 2022, Oncogene.

Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy‐naive metastatic castration‐resistant prostate cancer

Yanqing Wang, W. Xue, B. Dong, 2017, The Prostate.

Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.

Yanqing Wang, W. Xue, B. Dong, 2020, Urologic oncology.

The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy

W. Xue, L. Fan, Yinjie Zhu, 2023, International Urology and Nephrology.

PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study

Wei Xue, Yanqing Wang, B. Dong, 2022, Asian journal of andrology.

Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population

Yanqing Wang, W. Xue, B. Dong, 2017, Journal of Cancer Research and Clinical Oncology.

Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer

W. Xue, B. Dong, L. Fan, 2019, The Prostate.

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer

Yanqing Wang, Wei Chen, B. Dong, 2023, Translational oncology.

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer

Wei Xue, Yanqing Wang, B. Dong, 2023, Cancer research and treatment.

Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination

Wei Xue, Yanqing Wang, B. Dong, 2021, The Journal of urology.

JU Insight Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer

Wei Xue, B. Dong, L. Fan, 2022 .

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits

Wei Xue, Yanqing Wang, B. Dong, 2023, Frontiers in Oncology.

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers

Pengfei Ma, G. Zhuang, B. Dong, 2023, The Journal of clinical investigation.

Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer

W. Xue, B. Dong, L. Fan, 2021, The Journal of urology.